Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for ...

Primary liver cancer is the third cause of cancer death worldwide with 906,000 new cases and 830,000 deaths. Of these, 75-85% of patients are hepatocellular carcinoma (HCC), while the remaining 15-25% ...

The 2011 American Association for the Study of Liver Diseases (AASLD) guideline [10] recommends surveillance with non–contrast-enhanced hepatic ultrasound when the HCC risk is > 1.5% per year ...

Contacts International Contrast Ultrasound Society Linda Maiman Feinstein, Advisor 847-624-1844 or 312-876-2563 [email protected] Robin J. Adams, Director of Communication 202-408-3946 ...

The causes and treatments of liver cancer – as cases set to double fuelled by obesity - Many adults remain unaware of the ...

In a retrospective cohort study, researchers evaluated 2,053 patients with cirrhosis (mean age 59.5 years; 58.1% men) who underwent repeat HCC screening to assess the quality of ultrasound ...

One of the largest criticisms of ultrasound in HCC screening is variability in sensitivity, ranging between 32% and 89% when used alone,” Haley Schoenberger, MD, from The University of Texas ...

FibroScan is a type of ultrasound test that can help diagnose liver cancer. It measures liver stiffness, which can point to some liver diseases and, possibly, cancer.

The study of liver cancer, or Hepatocellular carcinoma (HCC), included 229 Indigenous and 3587 non-Indigenous HCC cases in South Australia, Queensland and the Northern Territory.